1 / 55

Neal Maskrey / Jonathan Underhill National Prescribing Centre Liverpool UK neal.maskrey@npc.nhs.uk

Dolphins and cows. Neal Maskrey / Jonathan Underhill National Prescribing Centre Liverpool UK neal.maskrey@npc.nhs.uk. why evidence-based practice doesn’t happen as often as it sometimes should. what should we be doing differently?. BTS Asthma guidelines 1997.

dixie
Download Presentation

Neal Maskrey / Jonathan Underhill National Prescribing Centre Liverpool UK neal.maskrey@npc.nhs.uk

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Dolphins and cows Neal Maskrey / Jonathan Underhill National Prescribing Centre Liverpool UK neal.maskrey@npc.nhs.uk

  2. why evidence-based practice doesn’t happen as often as it sometimes should what should we be doing differently?

  3. BTS Asthma guidelines 1997 BTS/SIGN Asthma guidelines 2004, 2005, 2007

  4. The doxazosin arm of ALLHAT?Hypertension 2003; 42: 239-246, Ann Intern Med 2002; 137: 313-320, JAMA 2000; 283: 1967-1975 Increased risk of stroke (RR 1.26), combined CVD (RR 1.20) and heart failure (RR 1.80) with doxazosin

  5. Prescribing of alpha-blockers in the US following ALLHATStafford RS, et al. JAMA 2004; 291: 54-62

  6. ALLHAT (doxazosin arm) PUBLISHED

  7. Trends in the prescribing of alpha blocking drugs in England

  8. Cox IIsMeReC Briefing 2002; 20 The GI safety of rofecoxib and celecoxib has been assessed in large clinical outcome trials which, on first analysis, show benefits over non-selective NSAIDs in the incidence of serious upper GI complications. However, longer-term GI data from the celecoxib study (CLASS) and cardiovascular adverse event data from the rofecoxib study (VIGOR) have questioned the risk/benefit profile of these new drugs and, until they are better understood, it seems sensible not to use them routinely in large numbers of people.

  9. Trends in Prescribing of NSAIDs in General Practice in England

  10. MeReC Extra 30November 2007 NSAIDs - GI and CV risk Long-term, randomised controlled trials (RCTs) have demonstrated that coxibs cause a small increased risk of thrombotic events in comparison with placebo. The excess risk was estimated to be about three cases per 1000 users treated for one year. This risk appears to increase with dose and persists throughout treatment.

  11. ….following a review of the evidence in October 2006, the Commission on Human Medicines (CHM) advised that there was sufficient evidence to suggest that traditional NSAIDs may also be associated with a small increased risk of thrombotic events when used at high doses and for long-term treatment. Furthermore, they identified that not all traditional NSAIDS carried the same CV risk: Naproxen 1000mg/day may be associated with a lower risk of thrombotic events than coxibs. Ibuprofen …..at low doses (e.g. 1200mg/day) …. does not suggest an increase [in] thrombotic risk Diclofenac 150mg/day has a thrombotic risk profile similar to that of etoricoxib▼ 60/90mg, and possibly other coxibs.

  12. Diclofenac accounted for 46% of all NSAID prescribing …in primary care in England ……. If the excess risk for CV events is the same as COX-2 inhibitors (3 per 1000 patients per year) then approximately 2000 additional or premature CV events per year could be caused by diclofenac prescribing, compared with no treatment.

  13. #1 However good the information is, on its own it is usually insufficient to change practice

  14. Work harder • Be more effective • Be imaginative and try some new things

  15. 1. Work harder • I’m not working hard enough • My workload is just right • I’m working too hard

  16. Without innovation, public services costs tend to rise faster than the rest of the economy. Without innovation, the inevitable pressure to contain costs can only be met by forcing already stretched staff to work harder. Mulgan G & Albury D (2003). Innovation in the Public Sector. Strategy Unit, London.

  17. #2 It’s hard to find NHS workers who have substantial spare capacity

  18. 2. Be more effective

  19. 2003 1994 2007

  20. Summary of recommendations • Incentive scheme for all practices • Better co-ordination of resources promoting rational prescribing • Better information • Education • Audit • Formularies and guidelines • Use skills of community pharmacists • Practice visits should be better targeted, more focussed, effectively followed up • Summarise information for prescribers • Improve local consensus • Involve and educate patients

  21. The median effect size overall was approximately 10% improvement in absolute terms. Grimshaw J, et al. Implementing clinical guidelines: current evidence and future implications: Journal of Continuing Education in the health professions 2004; 24: S31-S37. • The only factors that had a significant relationship with implementation of these important prescribing changes were an innovative approach among the doctors (most practitioners were cautious of change), and fundholding status. Salisbury C, et al. The implementation of evidence-based medicine in general practice prescribing. BJGP 1998; 48; 1849-1852. • 102 trials of educational interventions in the health care professions published between 1970 and 1993 inclusive. • Dissemination-only strategies, such as conferences or the mailing of unsolicited materials, demonstrated little or no changes in health professional behaviour or health outcome when used alone. • More complex interventions, such as the use of outreach visits or local opinion leaders, ranged from ineffective to highly effective but were most often moderately effective (resulting in reductions of 20% to 50% in the incidence of inappropriate performance). Oxman AD, et al. CMAJ 1995; 153: 1423-1431

  22. #3 If it was possible to deliver implementation strategies with 100% effectiveness, the best results we could expect are a shift in the desired direction of 10-50%.

  23. Greenhalgh T, et al. NCCSDO. April 2004 Let it happen Help it happen Make it happen Marketing: based on health promotion and social marketing theories. Attractive product, adapted to local needs (after assessment). Stepwise approach, multiple channels for communication Educational: based on adult learning theories. Focus on internal motivation of professionals. Bottom up, PBL, small interactive groups Epidemiological: based on rational, cognitive theories; information. Guideline development; dissemination via courses, journals, mailing

  24. Let it happen Help it happen Make it happen Social interaction: based on social learning and innovation theories, social influence and power theories. Peer review in local networks, outreach visits, opinion leaders, patient mediated interventions Organisational: based on management & system theories. Create structural and organisational conditions to improve care. Re-engineering care processes, TQM, team building, leadership. Behavioural: based on learning theory. Control performance by audit, feedback, reminder systems, £, sanctions. Coercive: based on economic, power and learning theories. Regulations, budgeting, contracting.

  25. #4 The NHS mostly does things to clinicians, rather than helping them acquire for themselves the knowledge, skills and attitudes to do a better job

  26. The NHS professional bureaucracy • Front line staff have a large measure of control over decisions • Hierarchical directives issued by those nominally in control often have limited impact – even resisted • Negotiation, not imposition • Collegial influences – credibility of professionals at their core, not simply those in formal positions of “authority” Mintzberg H. The Structuring of Organisations: a synthesis of research. 1979

  27. 3. Be imaginative

  28. information management cognitive psychology explaining risks and benefits to patients

  29. information management

  30. information management • Volume of published material is unmanageable • Reading is haphazard • Formal CPD is haphazard

  31. "We surveyed one acute medical take in our hospital. In a relatively quiet take, we saw 18 patients with a total of 44 diagnoses. The guidelines that the on call physician should have read remembered and applied correctly for those conditions came to 3679 pages. This number included only NICE, the Royal Colleges and major societies from the last 3 years. If it takes 2 min to read each page, the physician on call will have to spend 122h reading to keep abreast of the guidelines" (for one 24h on-call period). Allen D, Harkins KJ. Lancet 2005; 365: 1768

  32. More reading? • Potential journals 10,000 • Potential new articles per week 40,000 • Even if 97% are not relevant (no POOs) 1,200 • Time to read each article 15minutes • 10h a day, 6 days a week = 240 articles. • So at the end of the first week you are about 4 weeks behind in your reading. • At the end of the first month, you are 4 months behind in your reading. • And at the end of the first year you are almost 5 years behind in your reading.

  33. Effect of exercise on pain in knee OARoddy E, et al. Ann Rheum Dis 2005; 64: 544-8

  34. Evidence-based treatment for the patient Clinician reading journals

  35. Information Mastery requires two different approaches to managing information: • Foraging - a method of being alerted to new relevant, valid information when it is published • Hunting - a method of finding information when it is needed • NPC would add a third:- • Hot-synching – clinicians rapidly checking once or, at the most, twice a year that their key approaches for the management of conditions they see commonly still match the best evidence

  36. What are the criteria used when looking for the best answer or important evidence? Slawson DC and Shaughnessy AF. J Am Board Fam Pract 1999; 12: 444-449 Usefulness = Relevance x ValidityWork

  37. How can we quickly spot what is NOT important to us? • Not RELEVANT • Upstream to clinical decisions being made, e.g. animal or in vitro studies • Study populations and / or settings do not reflect question type, practice population and settings • Not VALID • Poor study design • Bias and confounding • Measurement validity • Insufficient power

  38. So, filtering for relevance • Feasible (intervention) • Outcomes (patient-orientated) • Common (condition) • Change in practice required

  39. DOOs can mislead and don’t always relate to POOsEbell M, et al. Am Fam Physician 2004; 69: 548–56

  40. If the answer to any of those is “no” I don’t know and I don’t care

  41. After checking it is relevant, is the answer likely to be valid? • How to quickly spot the fatal flaws: • Is it a high level of evidence? • Is it statistically significant? • Is it clinically significant?: • Do you understand what the the numbers tell you? • Absolute vs. relative risk vs. NNT • Was there enough people in the study for long enough? • Was the allocation concealed?

  42. Reading and critical appraisal MUST (largely) be replaced by reading pre-digested sources of evidence from trusted sources

  43. Cochrane Library NICE, (NSFs) Clinical Evidence InfoPOEMs, Prodigy BestTreatments NPC ref sheets EBM DTB MeReC Bandolier “Ivy League” journals Textbooks Usefulness Medline Be an Information Master!Slawson DC and Shaughnessy AF InfoRetriever, DrCompanion, self-assembly

More Related